Importance of classical morphology in the diagnosis of myelodysplastic syndrome

Research output: Contribution to journalArticlepeer-review


Myelodysplastic syndromes (MDS) are hematopoietic stem cell disorders characterized by dysplastic, ineffective, clonal and neoplastic hematopoiesis. MDS represent a complex hematological problem: differences in disease presentation, progression and outcome have necessitated the use of classification systems to improve diagnosis, prognostication, and treatment selection. However, since a single biological or genetic reliable diagnostic marker has not yet been discovered for MDS, quantitative and qualitative dysplastic morphological alterations of bone marrow precursors and peripheral blood cells are still fundamental for diagnostic classification. In this paper, World Health Organization (WHO) classification refinements and current minimal diagnostic criteria proposed by expert panels are highlighted, and related problematic issues are discussed. The recommendations should facilitate diagnostic and prognostic evaluations in MDS and selection of patients for new effective targeted therapies. Although, in the future, morphology should be supplemented with new molecular techniques, the morphological approach, at least for the moment, is still the cornerstone for the diagnosis and classification of these disorders.

Original languageEnglish
Article numbere2015035
JournalMediterranean Journal of Hematology and Infectious Diseases
Issue number1
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Hematology
  • Infectious Diseases


Dive into the research topics of 'Importance of classical morphology in the diagnosis of myelodysplastic syndrome'. Together they form a unique fingerprint.

Cite this